Development of a method for assessing the antitumor activity of chemotherapeutic agents using human tumor xenografts.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001853:Bone Marrow / Q000528:radiation effects; D016026:Bone Marrow Transplantation; D002277:Carcinoma / Q000188:drug therapy; D002330:Carmustine / Q000627:therapeutic use; D002945:Cisplatin / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007106:Immune Sera; D007165:Immunosuppression Therapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D011817:Rabbits / Q000276:immunology; D011829:Radiation Dosage; D011830:Radiation Effects; D013601:T-Lymphocytes / Q000276:immunology; D013934:Thymectomy; D013950:Thymus Gland / Q000276:immunology / Q000528:radiation effects; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D007106:Immune Sera; D002945:Cisplatin; D005472:Fluorouracil; D002330:Carmustine; D008727:Methotrexate